Hemei Pharmaceutical
和美药业
Hemei Pharmaceutical
Biotech/Healthcare
Xiajiang Hemei Pharmaceutical Co., Ltd., a subsidiary of Hemei (Hong Kong) Group, was established in March 2012 with a total investment of nearly RMB 200 million. The company occupies approximately 13 acres and is primarily being developed as Hemei Group’s industrialization and global drug supply…
Latest round: Series D (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.